拉米夫定,Lamivudine
1)Lamivudine拉米夫定
1.Lamivudine for Prophylaxis Against Hepatitis B Virus Reinfection Following Orthotopic Liver Transplantation:An Clinical Analysis;拉米夫定预防肝移植后乙型肝炎病毒再感染的临床分析
2.Predicting the Efficacy of 52-weekLamivudine Treatment by Testing Hepatitis B Virus DNA Levels at 4-week;拉米夫定治疗4周检测HBV DNA水平对52周疗效的预测
3.Lamivudine treatment for chronic hepatitis B and observation of platelet;拉米夫定治疗慢性乙型肝炎患者血小板变化的观察
英文短句/例句
1.Effect of combined use of stavudine,lamivudine and nevirapine on AIDS patients司他夫定、拉米夫定、奈韦拉平联合治疗AIDS效果
2.Determination of dextroisomer in Lamivudine by HPLCHPLC测定拉米夫定中的右旋异构体
3.The Relationship between HBV Genotype and the Virology Response of Lamivudine;HBV基因型与拉米夫定抗HBV疗效的关系
4.A Study of the Interaction Mechanism between Lamivudine and Bovine Serum Albumin;拉米夫定与牛血清白蛋白的作用机制
5.Evaluation on the effects of combined therapy with Stavudine,Lamivudine and Nevirapine in HIV/AIDS司他夫定、拉米夫定联合奈韦拉平治疗艾滋病患者12例效果评估
6.RP-HPLC determination of lamivudine and its related substancesRP-HPLC法测定拉米夫定的含量及有关物质
7.Determination of lamivudine in urine with RP-HPLC反相高效液相色谱法测定人尿拉米夫定浓度
8.The study of efficacy and side effects of telbivudine and lamivudine for treatment of patients with chronic hepatitis B替比夫定与拉米夫定治疗慢性乙型肝炎临床疗效比较研究
9.34 patients received interferon alpha and lamivudine simultaneously for 26 weeks, then lamivudine alone for another 26 weeks.治疗组34例,同时使用α-干扰素和拉米夫定26周,随后单用拉米夫定26周;
10.A META-ANALYSIS OF ADEFOVIR DIPIVOXIL ALONE OR IN COMBINATION WITH LAMIVUDINE IN PATIENTS WITH LAMIVUDINE-REFRACTORY CHRONIC HEPATITIS B阿德福韦酯单用或联合拉米夫定治疗拉米夫定耐药慢性乙型肝炎的Meta分析
11.A observation on the efficacy of Adefovir dipivoxil combined with Lamivudine for chronic hepatitis B patients with Lamivudine-resistant阿德福韦酯联合拉米夫定治疗拉米夫定耐药慢性乙型肝炎疗效观察
12.Studies on effect of adefovir dipivoxil monotherapy or combination therapy with lamivudine for patients with lamivudine-resistant chronic hepatitis B阿德福韦酯单药或联合拉米夫定治疗拉米夫定耐药慢性乙型肝炎患者的临床研究
13.To study the influence of EVR on the treatment of chronic hepatitis B with Lamivudine.研究影响拉米夫定治疗慢性乙肝疗效的因素。
14.Study on Effect of Lamivudine in the Treatment of 36 Patients with CHB and HBV Carrier拉米夫定治疗慢性乙肝及乙肝病毒携带者36例
15.The Efficacy of Thymosin-α_1 on Accelerating Lamivudine Treatment in Patients with Chronic Hepatitis B胸腺肽α_1促进拉米夫定抗乙型肝炎病毒的疗效
16.The analysis of effectiveness and cost of lamivudine in treatment of chronic hepatitis拉米夫定治疗慢性乙型肝炎疗效及费效分析
17.Clinical Studies of Lamivudine Anti-virus Treatment in Patients with Chronic Hepatitis B;拉米夫定抗病毒治疗慢性乙型肝炎的临床研究
18.Study on Relationship between Leptin Levels and Severity of Liver Fibrosis in Chronic Hepatitis B and the Effects of Lamivudine on Them;瘦素与肝纤维化的关系及拉米夫定对其影响
相关短句/例句
Lamivudine拉夫米定
3)Lamivudine Tablets拉米夫定片
4)Lamivudine(LMVD)拉米夫定(LMVD)
1.The thermal decomposition of Lamivudine(LMVD) is measured by thermogravimetry (TG) and differential scanning calorimetry(DSC) in Nitrogen.采用热重法(TG)和差示扫描量热法(DSC)测定了拉米夫定(LMVD)在氮气氛中的热分解过程,结果表明LMVD的热分解过程是一个二阶段过程。
5)Lamivudine-resistance拉米夫定耐药
1.102 patients with lamivudine-resistance chronic hepatitis B were randomly divided into control group, IFN-αgroup and combination group.探讨治疗拉米夫定耐药的慢性乙型肝炎的中西医结合疗法。
6)Lamivudine-resistant拉米夫定耐药
1.The Curative Effect Observation of Adefovir Dipivoxil forLamivudine-resistant Chronic Hepatitis B(A Report of 126 Cases);阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎126例疗效观察
延伸阅读
拉米夫定分子式：C8H11N3O3S分子量：暂无CAS号：134678-17-4性质：暂无制备方法：暂无用途：肝胆疾病用药。
